lepirudin (rDNA)
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
le-peer-yoo-din
To hear audio pronunciation of this topic, purchase a subscription or log in.
Trade Name(s)
- Refludan
Ther. Class.
Pharm. Class.
thrombin inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Lepirudin (rDNA)." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_.
Vallerand AHA, Sanoski CAC, Quiring CC. Lepirudin (rDNA). Davis's Drug Guide. F.A. Davis Company; 2024. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_. Accessed October 10, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Lepirudin (rDNA). In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_
Vallerand AHA, Sanoski CAC, Quiring CC. Lepirudin (rDNA) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 October 10]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - lepirudin (rDNA)
ID - 51437
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51437/all/lepirudin__rDNA_
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -